EC-0489

N/A

Report date: 2023/11/24 17:18:01

NME

Base Information

Drug NameEC-0489

Drug Alias NameEC-0489

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFolate receptor alpha antagonists

TargetsFolate receptor alpha

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEndocyte Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A